Market landscape of BioMEMS and microsystem market in healthcare
The BioMEMS and microsystem market in the healthcare market are expected to witness a significant growth through the forecast period, growing at a CAGR of around 25%. The primary driver for the growth of the market is the development of patient monitoring equipment, which also helps in detecting early symptoms of diseases, thus reducing the mortality rate.
BioMEMS and microsystems play a vital role in the clinical and biomedical applications by monitoring some of the most critical health-related challenges such as the cost of health care and disease prevention techniques. Moreover, with the introduction of BioMEMS devices there is a massive possibility of improving the delivery systems of the transdermal drug, which, at present, are limited to passive diffusion devices.
Segmentation of the BioMEMS and microsystem market in healthcare by application
- Microfluidics
- Micro dispensers for drug delivery
- Low meters
- Others
The BioMEMS and microsystems market will witness a rapid growth in the forecast period due to the increased use of microfluidics in healthcare applications. The microfluidic segment constitutes the largest share in the BioMEMS and microsystems market, growing at a CAGR of almost 27%.
Geographical segmentation of the BioMEMS and microsystem market in healthcare
The Americas is the largest contributor to the BioMEMS and microsystem market in healthcare, accounted for about 50% of the market share, which is mainly due to the increasing demand of lifestyle products for health monitoring.
Primary vendors of the BioMEMS and microsystem market in healthcare
The top vendors of the BioMEMS and microsystem market in healthcare are:
- Bluechiip
- Cepheid
- Given Imaging
- Integrated Sensing
One advantage of the BioMEMS device is that it can be implanted into a specific region of the body for localized drug therapy, which is a major trend captivating the vendors and simultaneously boosting the market growth in the forecast period.
Some other prominent vendors in the market include Becton, Dickinson and Company, Boston Scientific, CapitalBio, e2v, Heimann Sensor, Lepu Medical, Mec, Micron Technology, Nanopass, OMRON, Teledyne DALSA, and United Gene High-Tech Group.
Other section of the report includes an analysis of the following
- Key drivers, challenges, trends, and their impact on the BioMEMS and microsystem market in healthcare
- Five forces analysis of the BioMEMS and microsystem market in healthcare
- Comprehensive breakdown of the key customer segments
- Detail overview of the market size and forecast
- Key vendor analysis, including their product and distribution segments
Related reports: